Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free DFNS Stock Alerts

Trading of Nukkleus was halted at 02:06 PM EST due to "LULD Pause".

Nukkleus (DFNS) Financials

Nukkleus logo
$6.57 +2.31 (+54.23%)
As of 04:00 PM Eastern
Compare
Annual Income Statements for Nukkleus

Annual Income Statements for Nukkleus

This table shows Nukkleus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 9/30/2022 9/30/2023 9/30/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -0.02 -0.32 -0.60 -12 -17 -8.52 79
Consolidated Net Income / (Loss)		 -0.02 -0.32 -0.60 -12 -17 -8.52 79
Net Income / (Loss) Continuing Operations		 -0.02 -0.32 -0.60 -12 -17 -7.38 77
Total Pre-Tax Income 		-0.02 -0.14 -0.60 -12 -17 -7.38 77
Total Revenue		 0.00 0.00 0.07 -0.02 0.00 0.00 -21
Net Interest Income / (Expense)		 0.00 0.00 0.00 -0.00 0.00 0.00 0.28
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.28
Other Interest Income		 - 0.00 0.00 - - 0.00 0.28
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 0.00 0.00 0.07 -0.01 0.00 0.00 -21
Other Service Charges		 0.00 - - -0.01 - 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments		 0.00 - 0.07 - 0.00 0.00 -21
Total Non-Interest Expense		 0.02 0.15 0.67 10 16 7.11 33
Other Operating Expenses		 - - - 4.98 2.87 6.71 29
Impairment Charge		 - - - 4.31 12 0.39 4.34
Other Special Charges		 0.02 0.15 0.67 - 0.00 0.00 0.00
Nonoperating Income / (Expense), net		 - - - - 0.03 -0.27 130
Income Tax Expense		 - - - 0.00 - 0.00 0.01
Net Income / (Loss) Discontinued Operations		 - - - - - -1.14 2.03
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - 0.00 0.08
Basic Earnings per Share		 ($0.04) ($0.09) ($0.10) ($1.21) ($13.84) ($4.93) $8.45
Weighted Average Basic Shares Outstanding		 562.77K 3.70M 6.11M 9.77M 1.26M 1.73M 8.36M
Diluted Earnings per Share		 ($0.04) ($0.09) - - - ($4.93) $7.96
Weighted Average Diluted Shares Outstanding		 562.77K 3.70M 6.11M 1.82M 1.26M 1.73M 9.25M

Quarterly Income Statements for Nukkleus

This table shows Nukkleus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -14 -9.13 -2.43 4.46 -1.41 103 3.02 -16 -11 -27
Consolidated Net Income / (Loss)		 -14 -8.78 -2.43 4.46 -1.77 103 3.02 -16 -11 -26
Net Income / (Loss) Continuing Operations		 -14 -9.13 -2.10 -1.22 5.07 103 3.24 -16 -13 -26
Total Pre-Tax Income 		-14 -8.93 -2.10 -1.22 4.86 103 3.24 -16 -13 -26
Total Revenue		 -0.01 0.02 -0.01 0.39 -0.40 -0.20 -0.67 -7.48 -12 2.85
Net Interest Income / (Expense)		 - -0.01 -0.01 -0.02 0.03 -0.20 -0.02 0.00 0.33 -0.80
Total Interest Income		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.28 1.79
Investment Securities Interest Income		 - - - - - 0.00 - - - 1.79
Total Interest Expense		 - 0.01 0.01 0.02 -0.03 0.20 0.02 0.00 -0.05 2.59
Long-Term Debt Interest Expense		 - - - - - 0.20 - - - 2.59
Total Non-Interest Income		 -0.01 0.03 0.00 0.40 -0.43 0.00 -0.66 -7.48 -13 3.65
Other Non-Interest Income		 - - - 0.00 - 0.00 -0.80 - - 3.65
Total Non-Interest Expense		 13 3.01 2.09 1.60 0.41 1.51 -3.87 4.77 135 7.82
Marketing Expense		 0.00 0.02 - - - 0.00 - - - 0.43
Other Operating Expenses		 0.43 2.99 2.06 1.16 0.51 1.51 -3.94 4.54 131 7.39
Nonoperating Income / (Expense), net		 - - 0.00 0.00 - 105 0.02 -4.17 135 -21
Income Tax Expense		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.01 0.04
Net Income / (Loss) Discontinued Operations		 - - -0.33 5.67 - -0.18 -0.22 -0.06 2.49 -0.10
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - 0.00 - - - 0.80
Basic Earnings per Share		 ($11.27) ($0.85) ($1.38) $2.18 ($0.82) $20.76 $0.58 ($2.02) ($1.32) ($1.01)
Weighted Average Basic Shares Outstanding		 1.26M 10.56M 1.75M 2.04M 1.73M 4.96M 5.25M 8.12M 8.36M 28.16M
Diluted Earnings per Share		 ($11.27) - $0.00 $2.18 ($0.82) $18.15 $0.54 ($2.02) ($1.32) ($1.14)
Weighted Average Diluted Shares Outstanding		 1.26M - 0.00 2.04M 1.73M 5.67M 5.62M 8.12M 9.25M 30.87M
Weighted Average Basic & Diluted Shares Outstanding		 0.00 - - 16.79M 0.00 5.36M 7.07M 16.65M 0.00 60.27M

Annual Cash Flow Statements for Nukkleus

This table details how cash moves in and out of Nukkleus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 9/30/2022 9/30/2023 9/30/2024 12/31/2025
Net Change in Cash & Equivalents		 0.03 0.69 -0.03 1.58 -1.92 -3.56 -3.91
Net Cash From Operating Activities		 -0.02 -0.14 -0.43 1.62 -1.23 -3.82 -6.20
Net Cash From Continuing Operating Activities		 -0.02 -0.14 -0.46 1.62 -1.23 -0.89 -6.15
Net Income / (Loss) Continuing Operations		 -0.02 -0.32 -0.60 -12 -17 -7.38 81
Consolidated Net Income / (Loss)		 -0.02 -0.32 -0.60 -12 -17 -8.52 79
Net Income / (Loss) Discontinued Operations		 - - - - - -1.14 2.03
Depreciation Expense		 - - - - - 0.00 0.00
Amortization Expense		 - - - 2.69 2.38 0.32 0.00
Non-Cash Adjustments to Reconcile Net Income		 0.00 -0.00 -0.07 6.91 12 0.72 -83
Changes in Operating Assets and Liabilities, net		 0.00 0.18 0.21 3.86 0.34 5.66 0.34
Net Cash From Discontinued Operating Activities		 - - - - - -2.93 -0.05
Net Cash From Investing Activities		 0.00 -46 -1.38 -0.04 -1.11 0.13 -180
Net Cash From Continuing Investing Activities		 0.00 -46 -1.38 -0.04 -1.11 0.00 -179
Purchase of Property, Leasehold Improvements and Equipment		 - - - - - 0.00 -0.03
Acquisitions		 - - - - - 0.00 -3.50
Purchase of Investment Securities		 0.00 -46 -1.38 -0.04 -1.96 0.00 -176
Sale and/or Maturity of Investments		 - - 0.00 - - - 0.00
Other Investing Activities, net		 - - - 0.00 0.85 - 0.45
Net Cash From Discontinued Investing Activities		 - - - - - 0.13 -0.96
Net Cash From Financing Activities		 0.05 47 1.38 0.00 0.42 3.00 182
Net Cash From Continuing Financing Activities		 0.05 47 1.81 0.00 0.42 2.58 182
Issuance of Debt		 0.18 0.06 1.38 0.00 0.42 1.43 0.00
Issuance of Common Equity		 0.03 47 - - - 1.00 182
Repayment of Debt		 - - 0.00 - 0.00 0.00 -0.09
Other Financing Activities, Net		 -0.16 -0.24 0.43 - 0.00 - 0.00
Net Cash From Discontinued Financing Activities		 - - - - - 0.42 0.00
Cash Interest Paid		 - - - 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for Nukkleus

This table details how cash moves in and out of Nukkleus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 6/30/2024 9/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -1.10 0.14 -2.16 11 -13 -2.12 -5.80 8.53 -2.37 3.73
Net Cash From Operating Activities		 -0.61 -0.74 -1.08 -1.39 -0.61 -1.34 -1.35 -2.51 -1.00 -4.93
Net Cash From Continuing Operating Activities		 -0.61 -0.74 -0.01 -0.89 0.74 -1.62 -1.36 -1.96 -1.20 -4.57
Net Income / (Loss) Continuing Operations		 -14 -8.93 5.57 -1.22 -2.81 103 3.24 -16 -9.41 -26
Consolidated Net Income / (Loss)		 -14 -8.93 4.88 4.46 -8.93 103 3.02 -16 -11 -26
Net Income / (Loss) Discontinued Operations		 - - - 5.67 -6.12 -0.18 -0.22 -0.06 2.49 -0.10
Depreciation Expense		 - - - - - 0.00 0.00 0.00 0.00 0.02
Amortization Expense		 0.60 0.00 0.03 0.28 0.00 0.14 0.19 - -0.32 0.17
Non-Cash Adjustments to Reconcile Net Income		 12 2.09 -1.76 0.11 0.29 -105 -5.15 12 15 22
Changes in Operating Assets and Liabilities, net		 -0.10 -0.05 2.29 -0.06 3.48 -0.23 0.36 2.74 -2.53 -0.39
Net Cash From Discontinued Operating Activities		 - - - -0.50 -1.35 0.28 0.01 -0.54 0.20 -0.36
Net Cash From Investing Activities		 -0.91 0.13 -0.13 - 0.13 -0.81 -0.70 -2.00 -176 -3.82
Net Cash From Continuing Investing Activities		 -0.91 0.13 -0.13 - - -0.81 -0.70 -2.00 -175 -3.82
Purchase of Property, Leasehold Improvements and Equipment		 - - - - - -0.01 -0.00 -0.00 -0.01 -0.15
Acquisitions		 - - - - - -0.80 -0.70 - - 0.00
Purchase of Investment Securities		 -1.77 0.00 - - - 0.00 - - -172 -5.05
Sale and/or Maturity of Investments		 - - - - - 0.00 - - - 0.24
Other Investing Activities, net		 0.85 0.13 - - - 0.00 - - - 1.14
Net Cash From Financing Activities		 0.42 0.75 0.76 0.88 0.61 0.00 -0.88 9.23 174 12
Net Cash From Continuing Financing Activities		 0.42 0.75 0.18 0.88 0.77 0.00 -0.88 9.23 174 12
Issuance of Debt		 0.42 0.68 0.17 0.88 -0.29 0.00 - - - 3.94
Issuance of Common Equity		 - - - - 0.92 0.00 - 9.23 173 10
Repayment of Debt		 - -0.08 0.08 - - 0.00 - - 0.78 -1.17
Payment of Dividends		 - - - - - 0.00 - - - -0.30

Annual Balance Sheets for Nukkleus

This table presents Nukkleus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 9/30/2023 12/31/2024 12/31/2025
Total Assets		 0.21 47 48 6.11 3.35 9.11 202
Cash and Due from Banks		 0.03 0.71 0.28 6.11 0.02 6.90 3.90
Restricted Cash		 - - - - - 0.00 0.05
Trading Account Securities		 0.00 46 47 - 0.39 0.00 0.25
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Customer and Other Receivables		 - - - - 2.71 - 1.64
Premises and Equipment, Net		 - - - - - 0.00 0.10
Goodwill		 - - - - - 0.00 7.69
Intangible Assets		 - - - - 0.03 0.00 7.40
Other Assets		 0.00 0.01 0.00 0.00 0.20 2.21 181
Total Liabilities & Shareholders' Equity		 0.21 47 48 6.11 3.35 9.11 202
Total Liabilities		 0.21 0.58 2.12 3.98 9.55 172 45
Short-Term Debt		 0.18 0.27 1.93 2.68 0.14 0.78 0.98
Long-Term Debt		 - - - - 0.84 1.68 0.00
Other Long-Term Liabilities		 0.00 0.25 0.18 0.01 2.18 165 44
Redeemable Noncontrolling Interest		 0.00 46 47 6.06 - 0.00 173
Total Equity & Noncontrolling Interests		 0.00 0.15 -1.83 -3.92 -6.19 -163 -16
Total Preferred & Common Equity		 0.00 0.15 -1.83 -3.92 -6.19 -163 -20
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 0.00 0.15 -1.83 -3.92 -6.19 -163 -20
Common Stock		 0.03 3.88 3.88 3.88 26 38 103
Retained Earnings		 -0.02 -3.73 -5.71 -7.80 -32 -201 -123
Accumulated Other Comprehensive Income / (Loss)		 - - - - 0.03 -0.03 0.00
Noncontrolling Interest		 - - - - - 0.00 4.21

Quarterly Balance Sheets for Nukkleus

This table presents Nukkleus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 3.35 2.38 1.23 1.12 8.60 7.15 13 315
Cash and Due from Banks		 0.69 0.86 0.65 0.54 4.46 1.52 7.61 7.36
Restricted Cash		 - - - - - - - 0.33
Trading Account Securities		 0.39 0.39 0.39 0.39 - - - 0.12
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Customer and Other Receivables		 2.04 0.03 0.05 0.02 - 0.13 0.24 0.09
Premises and Equipment, Net		 - - - - 0.01 0.01 0.02 0.56
Goodwill		 - - - - - - - 100
Intangible Assets		 0.03 0.03 0.03 0.02 - - - 13
Other Assets		 0.20 1.07 0.11 0.15 4.13 5.48 5.42 194
Total Liabilities & Shareholders' Equity		 3.35 2.38 1.23 1.12 8.60 7.15 13 315
Total Liabilities		 9.55 12 13 13 66 61 44 98
Short-Term Debt		 0.14 0.35 0.31 0.34 0.64 1.66 1.65 14
Other Short-Term Payables		 6.81 8.18 7.98 7.94 0.05 0.13 0.23 7.73
Long-Term Debt		 0.42 0.70 0.94 1.27 0.91 0.52 0.00 3.08
Other Long-Term Liabilities		 2.18 3.11 3.51 3.80 64 58 42 74
Redeemable Noncontrolling Interest		 - - - - - - - 175
Total Equity & Noncontrolling Interests		 -6.19 -9.95 -12 -12 -57 -53 -30 43
Total Preferred & Common Equity		 -6.19 -9.95 -12 -12 -57 -53 -30 36
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -6.19 -9.95 -12 -12 -57 -53 -30 36
Common Stock		 26 35 36 37 41 42 81 186
Retained Earnings		 -32 -45 -47 -49 -98 -95 -111 -150
Accumulated Other Comprehensive Income / (Loss)		 0.03 -0.03 -0.00 -0.01 -0.09 -0.22 -0.00 -0.02
Noncontrolling Interest		 - - - - - - - 6.36

Annual Metrics And Ratios for Nukkleus

This table displays calculated financial ratios and metrics derived from Nukkleus' official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 9/30/2022 9/30/2023 9/30/2024 12/31/2025
DEI Shares Outstanding		 0.00 6,111,000.00 6,111,000.00 4,451,927.00 1,814,696.00 1,814,696.00 1,814,696.00
DEI Adjusted Shares Outstanding		 0.00 763,875.00 763,875.00 556,491.00 226,837.00 226,837.00 226,837.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -0.42 -0.78 -21.29 -76.83 -37.56 346.64
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% 0.00% 2,246.05% -121.64% 100.00% 0.00% 0.00%
EBITDA Growth		 0.00% -601.46% -313.33% -1,202.63% -88.87% 53.94% -691.69%
EBIT Growth		 0.00% -601.46% -313.33% -1,651.72% -63.13% 58.50% -656.54%
NOPAT Growth		 0.00% -601.46% -313.33% -1,877.15% -44.53% 58.50% -980.64%
Net Income Growth		 0.00% -1,437.64% -88.56% -1,877.15% -47.13% 51.12% 1,023.01%
EPS Growth		 0.00% -125.00% 0.00% 0.00% 0.00% 0.00% 261.46%
Operating Cash Flow Growth		 0.00% -577.36% -214.36% 474.93% -176.28% -209.81% -62.34%
Free Cash Flow Firm Growth		 0.00% 0.00% 96.80% 2,415.48% -105.69% 7,807.28% -347.37%
Invested Capital Growth		 0.00% 24,779.73% 2.30% -89.86% -208.27% -2,986.30% 198.31%
Revenue Q/Q Growth		 0.00% 0.00% 570.80% -159.60% -100.00% -100.00% -723.52%
EBITDA Q/Q Growth		 0.00% 0.00% -71.08% -427.58% -20.32% 63.17% -155.23%
EBIT Q/Q Growth		 0.00% 0.00% -71.08% -609.47% -39.75% 63.29% -155.43%
NOPAT Q/Q Growth		 0.00% 0.00% -71.08% -700.78% -23.49% 72.86% -157.92%
Net Income Q/Q Growth		 0.00% 0.00% -35.37% -685.85% -25.88% 59.64% -10.49%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 59.64% -25.82%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -20.97% 226.52% -160.31% 0.00% -6.76%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 109.15% -107.59% 1,230.05% -436.06%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.41% -83.85% 7.47% -1,414.97% 649.92%
Profitability Metrics		 - - - - - - -
EBITDA Margin		 0.00% -4,736.93% -834.57% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% -4,736.93% -834.57% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% -10,383.56% -834.57% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 219.20% 100.00% 100.00% 102.01% 115.46% 102.64%
Interest Burden Percent		 100.00% 100.00% 100.00% 112.87% 99.80% 103.84% -142.52%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%
Return on Invested Capital (ROIC)		 0.00% -0.44% -0.89% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -96.12% -17.20% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -0.94% -0.41% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -476.57% -1.38% -1.31% -49.68% 858.93% 10.05% -2,557.11%
Cash Return on Invested Capital (CROIC)		 0.00% -198.83% -3.16% 131.47% 0.00% 0.00% -235.70%
Operating Return on Assets (OROA)		 0.00% -0.62% -1.27% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% -1.35% -1.27% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -476.57% 0.00% 0.02% 5.99% 2,140.50% 10.05% -76,146.87%
Return on Equity Simple (ROE_SIMPLE)		 -476.57% -205.25% 32.70% 302.19% 281.41% 5.22% -397.37%
Net Operating Profit after Tax (NOPAT)		 -0.01 -0.10 -0.42 -8.29 -12 -4.97 -54
NOPAT Margin		 0.00% -3,315.85% -584.20% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 3.40% 95.69% 16.31% 154.02% 297.50% 206.68% -7,721.01%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 4,836.93% 934.57% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -0.02 -0.14 -0.60 -10 -17 -7.11 -54
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.02 -0.14 -0.60 -7.80 -15 -6.79 -54
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 9,225.09 258.38 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 9,225.09 258.38 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 13,071.90 557.19 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.47
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 210.71%
Enterprise Value to Invested Capital (EV/IC)		 215.20 1.84 1.87 8.85 0.00 0.00 1.34
Enterprise Value to Revenue (EV/Rev)		 0.00 27,959.79 1,240.28 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 26.38 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 1.24 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 42.03 0.01 0.04 1.26 -0.16 -0.02 0.01
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 -0.14 -0.01 0.00
Financial Leverage		 42.03 0.01 0.02 0.10 -0.90 -0.02 -0.56
Leverage Ratio		 48.44 1.02 1.03 1.13 -2.33 -0.07 -34.39
Compound Leverage Factor		 48.44 1.02 1.03 1.27 -2.33 -0.08 49.01
Debt to Total Capital		 97.68% 0.58% 4.07% 55.66% -18.80% -1.52% 0.62%
Short-Term Debt to Total Capital		 97.68% 0.58% 4.07% 55.66% -2.66% -0.48% 0.62%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% -16.14% -1.04% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 99.09% 99.78% 125.75% 0.00% 0.00% 111.89%
Common Equity to Total Capital		 2.32% 0.33% -3.86% -81.41% 118.80% 101.52% -12.51%
Debt to EBITDA		 -8.82 -1.86 -3.23 -0.34 -0.07 -0.36 -0.02
Net Debt to EBITDA		 -7.48 3.06 -2.76 0.44 -0.07 0.66 0.06
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.06 -0.25 0.00
Debt to NOPAT		 -12.60 -2.66 -4.61 -0.32 -0.08 -0.49 -0.02
Net Debt to NOPAT		 -10.69 4.37 -3.94 0.41 -0.08 0.89 0.06
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.07 -0.34 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 99.66% 101.83% 112.06% -149.21% 0.00% -2,877.85%
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -46 -1.48 34 -1.96 151 -373
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -19,993.55%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 23,647.09 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 1,111.15 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 1,111.15 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.19 46 47 4.82 -5.21 -161 158
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 46 1.07 -43 -10 -156 319
Enterprise Value (EV)		 40 86 89 43 118 -0.43 211
Market Capitalization		 40 40 40 40 117 4.02 37
Book Value per Share		 $0.01 $0.03 ($0.30) ($0.88) ($3.41) ($94.52) ($2.37)
Tangible Book Value per Share		 $0.01 $0.03 ($0.30) ($0.88) ($3.43) ($94.52) ($4.17)
Total Capital		 0.19 46 47 4.82 -5.21 -161 158
Total Debt		 0.18 0.27 1.93 2.68 0.98 2.45 0.98
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.84 1.68 0.00
Net Debt		 0.15 -0.44 1.65 -3.43 0.96 -4.45 -2.97
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.03
Net Nonoperating Expense (NNE)		 0.01 0.22 0.18 3.55 5.44 3.55 -132
Net Nonoperating Obligations (NNO)		 0.18 0.27 1.93 2.68 0.98 2.45 0.98
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 2.69 2.38 0.32 0.00
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.09) ($0.10) ($0.21) ($13.84) $0.00 $8.45
Adjusted Weighted Average Basic Shares Outstanding		 0.00 3.70M 5.48M 4.64M 1.26M 0.00 8.36M
Adjusted Diluted Earnings per Share		 $0.00 ($0.09) ($0.10) $0.00 $0.00 $0.00 $7.96
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 3.70M 5.48M 1.82M 0.00 0.00 9.25M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($0.09) ($0.10) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 3.70M 6.11M 1.82M 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 0.00 0.00 0.05 -5.27 -3.64 -4.70 -49
Normalized NOPAT Margin		 0.00% 70.00% 70.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% -4,736.93% -834.57% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 -7,218.02 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 -5,702.86 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 -7,218.02 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 -5,702.86 0.00 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Nukkleus

This table displays calculated financial ratios and metrics derived from Nukkleus' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 1,814,696.00 1,814,696.00 1,814,696.00 1,814,696.00 1,814,696.00 1,814,696.00 1,814,696.00 1,814,696.00 1,814,696.00 1,814,696.00
DEI Adjusted Shares Outstanding		 226,837.00 226,837.00 226,837.00 226,837.00 226,837.00 226,837.00 226,837.00 226,837.00 226,837.00 226,837.00
DEI Earnings Per Adjusted Shares Outstanding		 -63.28 -38.70 -10.71 19.64 -7.79 453.89 13.31 -72.15 -48.41 -116.17
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -130.71% 643.65% -1,502.10% 12,583.94% -6,154.64% -1,129.58% -6,627.58% -2,030.16% -3,036.54% 1,547.72%
EBITDA Growth		 -32.98% -1,777.89% -1,181.78% -104.32% 93.53% 82.81% 261.86% -1,207.16% -18,219.87% -204.53%
EBIT Growth		 -39.40% -746.39% -177.11% -15.71% 93.83% 81.34% 252.62% -907.04% -18,176.25% -191.43%
NOPAT Growth		 -30.06% -687.36% -160.06% -0.60% 149.84% 72.73% 319.42% -897.28% -2,230.30% -104.00%
Net Income Growth		 -33.27% -674.14% -232.50% 468.28% 87.69% 1,272.90% 224.25% -467.33% -521.50% -125.59%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 87.69% 0.00% 0.00% -192.66% -60.98% -106.28%
Operating Cash Flow Growth		 -122.68% -112.65% 85.22% -210.81% -0.01% -81.88% -24.89% -80.05% -64.86% -267.14%
Free Cash Flow Firm Growth		 -99.22% -84.47% -68.57% -88.05% 58,617.45% 681.22% 275.62% 133.32% -363.26% -749.96%
Invested Capital Growth		 -208.27% -385.70% -448.61% -88.51% -2,986.30% -525.37% -398.42% -170.83% 198.31% 519.89%
Revenue Q/Q Growth		 -307.56% 101.63% -152.39% 3,967.81% -202.35% 50.36% -1,892.97% -1,009.68% -66.32% 122.91%
EBITDA Q/Q Growth		 -2,613.84% 45.63% 77.09% 55.18% 14.07% -94.76% -96.70% -461.95% -1,104.37% 96.76%
EBIT Q/Q Growth		 -1,141.15% 45.61% 77.06% 41.91% 33.79% -111.47% -96.88% -483.26% -1,101.62% 96.63%
NOPAT Q/Q Growth		 -1,051.98% 47.79% 76.53% 41.91% 670.76% -135.05% -96.88% -364.00% -1,119.20% 96.64%
Net Income Q/Q Growth		 -1,086.54% 47.36% 72.32% 283.39% -139.66% 5,927.63% -97.07% -642.16% 32.91% -139.99%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 283.39% -139.66% 2,313.41% -97.02% -474.07% 34.65% 13.64%
Operating Cash Flow Q/Q Growth		 -148.23% 20.50% -54.61% -28.51% 56.47% -121.56% -0.81% -85.27% 60.15% -393.41%
Free Cash Flow Firm Q/Q Growth		 -99.21% 624.59% 103.75% -64.82% 3,782.91% -71.93% -70.55% -78.15% -4,481.18% 30.70%
Invested Capital Q/Q Growth		 7.47% -47.04% -15.40% -3.38% -1,414.97% 65.40% 8.03% 43.83% 649.92% 47.79%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 0.00% -47,713.55% 0.00% -241.78% 0.00% 0.00% 0.00% 0.00% 0.00% -167.53%
EBIT Margin		 0.00% -47,731.57% 0.00% -313.86% 0.00% 0.00% 0.00% 0.00% 0.00% -174.12%
Profit (Net Income) Margin		 0.00% -45,876.95% 0.00% 1,149.00% 0.00% 0.00% 0.00% 0.00% 0.00% -923.95%
Tax Burden Percent		 103.00% 98.32% 115.95% -366.09% -36.34% 99.82% 93.27% 100.37% 81.56% 100.54%
Interest Burden Percent		 106.76% 97.76% 100.00% 100.00% -603.42% -6,052.88% 101.21% 133.04% 9.14% 527.77%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 858.93% 513.64% 467.96% 229.13% 10.05% -307.36% -334.83% -411.95% -2,557.11% -63.40%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -235.70% -140.89%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% -54.81% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 200.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 2,140.50% 751.01% 653.22% 229.13% 10.05% -307.36% -334.83% -411.95% -76,146.87% 8.35%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 247.80% 232.29% 172.58% 0.00% -180.40% -203.56% -288.79% 0.00% -140.13%
Net Operating Profit after Tax (NOPAT)		 -9.76 -6.25 -1.47 -0.85 4.86 -1.70 3.22 -8.50 -104 -3.48
NOPAT Margin		 0.00% -32,662.62% 0.00% -219.70% 0.00% 0.00% 0.00% 0.00% 0.00% -121.89%
Net Nonoperating Expense Percent (NNEP)		 251.30% 132.70% 46.79% -489.40% 386.43% -8,087.73% 11.63% 482.21% -5,401.06% 251.11%
SG&A Expenses to Revenue		 0.00% 109.85% 0.00% 13.75% 0.00% 0.00% 0.00% 0.00% 0.00% 15.11%
Operating Expenses to Revenue		 0.00% 15,711.04% 0.00% 413.86% 0.00% 0.00% 0.00% 0.00% 0.00% 274.12%
Earnings before Interest and Taxes (EBIT)		 -13 -9.13 -2.10 -1.22 -0.81 -1.70 3.20 -12 -147 -4.97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -12 -9.13 -2.09 -0.94 -0.81 -1.57 3.39 -12 -148 -4.78
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.61
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 12.17 0.00 0.00 11.46 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.65 0.57 0.65 0.47 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 153.58% 175.73% 153.33% 210.71% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.34 0.91
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 14.91 0.00 0.00 11.58 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.57 0.52 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.58 0.53 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.62 0.58 0.55 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.43 0.42 0.46 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 -0.16 -0.11 -0.11 -0.13 -0.02 -0.03 -0.04 -0.05 0.01 0.08
Long-Term Debt to Equity		 -0.14 -0.07 -0.08 -0.10 -0.01 -0.02 -0.01 0.00 0.00 0.01
Financial Leverage		 -0.90 -0.40 -0.36 -0.12 -0.02 -0.04 -0.05 -0.08 -0.56 0.11
Leverage Ratio		 -2.33 -0.71 -0.51 -0.24 -0.07 -0.16 -0.13 -0.34 -34.39 2.03
Compound Leverage Factor		 -2.49 -0.70 -0.51 -0.24 0.44 9.90 -0.13 -0.45 -3.14 10.70
Debt to Total Capital		 -18.80% -11.73% -12.18% -15.16% -1.52% -2.77% -4.26% -5.75% 0.62% 7.13%
Short-Term Debt to Total Capital		 -2.66% -3.89% -3.02% -3.23% -0.48% -1.15% -3.25% -5.75% 0.62% 5.81%
Long-Term Debt to Total Capital		 -16.14% -7.84% -9.16% -11.92% -1.04% -1.63% -1.01% 0.00% 0.00% 1.32%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 111.89% 77.40%
Common Equity to Total Capital		 118.80% 111.73% 112.18% 115.16% 101.52% 102.77% 104.26% 105.75% -12.51% 15.47%
Debt to EBITDA		 -0.07 -0.06 -0.07 -0.09 -0.36 -0.29 0.02 0.02 -0.02 -0.29
Net Debt to EBITDA		 -0.07 -0.01 -0.03 -0.06 0.66 0.54 0.01 -0.06 0.06 -0.16
Long-Term Debt to EBITDA		 -0.06 -0.04 -0.05 -0.07 -0.25 -0.17 0.00 0.00 0.00 -0.05
Debt to NOPAT		 -0.08 -0.06 -0.07 -0.09 -0.49 0.01 0.02 0.02 -0.02 -0.42
Net Debt to NOPAT		 -0.08 -0.01 -0.03 -0.06 0.89 -0.03 0.01 -0.06 0.06 -0.23
Long-Term Debt to NOPAT		 -0.07 -0.04 -0.05 -0.07 -0.34 0.01 0.00 0.00 0.00 -0.08
Noncontrolling Interest Sharing Ratio		 -149.21% -46.21% -39.59% 0.00% 0.00% 0.00% 0.00% 0.00% -2,877.85% 113.17%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.27 5.77 12 4.13 161 45 44 9.65 -423 -293
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% -13,420.00% -29,234.41% -65,197.71% -8,111.73% -3,199.35%
Free Cash Flow to Firm to Interest Expense		 0.00 777.25 1,172.43 266.40 0.00 228.76 2,609.29 0.00 0.00 -113.05
Operating Cash Flow to Interest Expense		 0.00 -99.41 -113.79 -89.66 0.00 -6.81 -79.93 0.00 0.00 -1.90
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -99.41 -113.79 -89.66 0.00 -6.86 -80.20 0.00 0.00 -1.96
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.17 0.00 0.00 1.28 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 -5.21 -8.90 -10 -11 -161 -56 -51 -29 158 234
Invested Capital Turnover		 0.00 0.00 0.00 -0.05 0.00 0.00 -0.17 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -10 -12 -13 -4.99 -156 -47 -41 -18 319 289
Enterprise Value (EV)		 118 12 0.00 5.82 -0.43 65 62 51 211 212
Market Capitalization		 117 11 0.00 4.75 4.02 67 61 57 37 22
Book Value per Share		 ($3.41) ($5.48) ($6.35) ($5.98) ($94.52) ($11.54) ($10.17) ($3.74) ($2.37) $1.28
Tangible Book Value per Share		 ($3.43) ($5.50) ($6.37) ($5.99) ($94.52) ($11.54) ($10.17) ($3.74) ($4.17) ($2.72)
Total Capital		 -5.21 -8.90 -10 -11 -161 -56 -51 -29 158 234
Total Debt		 0.98 1.04 1.25 1.61 2.45 1.54 2.18 1.65 0.98 17
Total Long-Term Debt		 0.84 0.70 0.94 1.27 1.68 0.91 0.52 0.00 0.00 3.08
Net Debt		 0.96 0.18 0.60 1.07 -4.45 -2.92 0.66 -5.96 -2.97 8.98
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.15
Net Nonoperating Expense (NNE)		 4.60 2.53 0.96 -5.31 6.63 -105 0.20 7.87 -93 23
Net Nonoperating Obligations (NNO)		 0.98 1.04 1.25 1.61 2.45 1.54 2.18 1.65 0.98 17
Total Depreciation and Amortization (D&A)		 0.60 0.00 0.00 0.28 0.00 0.14 0.19 0.00 -0.32 0.19
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($90.16) ($0.85) ($1.36) ($0.88) ($6.56) $20.76 $0.58 ($2.02) ($1.32) ($1.01)
Adjusted Weighted Average Basic Shares Outstanding		 157.42K 10.56M 1.75M 1.79M 216.02K 4.96M 5.25M 8.12M 8.36M 28.16M
Adjusted Diluted Earnings per Share		 ($90.16) $0.00 $0.00 $0.00 ($6.56) $18.15 $0.54 ($2.02) ($1.32) ($1.14)
Adjusted Weighted Average Diluted Shares Outstanding		 157.42K 0.00 0.00 2.10M 216.02K 5.67M 5.62M 8.12M 9.25M 30.87M
Adjusted Basic & Diluted Earnings per Share		 ($90.16) $0.00 $0.00 $0.00 ($6.56) $0.00 $0.00 $0.00 ($1.32) $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 2.10M 0.00 5.36M 7.07M 16.65M 0.00 60.27M
Normalized Net Operating Profit after Tax (NOPAT)		 -9.76 -6.25 -1.47 -0.58 3.40 -1.19 2.25 -8.50 -104 -3.48
Normalized NOPAT Margin		 0.00% -32,662.62% 0.00% -149.08% 0.00% 0.00% 0.00% 0.00% 0.00% -121.89%
Pre Tax Income Margin		 0.00% -46,660.89% 0.00% -313.86% 0.00% 0.00% 0.00% 0.00% 0.00% -918.97%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 -1,230.53 -209.00 -78.41 0.00 -8.65 188.99 0.00 0.00 -1.92
NOPAT to Interest Expense		 0.00 -842.05 -146.30 -54.89 0.00 -8.65 190.20 0.00 0.00 -1.34
EBIT Less CapEx to Interest Expense		 0.00 -1,230.53 -209.00 -78.41 0.00 -8.70 188.72 0.00 0.00 -1.98
NOPAT Less CapEx to Interest Expense		 0.00 -842.05 -146.30 -54.89 0.00 -8.70 189.92 0.00 0.00 -1.40
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Nukkleus’ latest quarter shows a sharp improvement in cash flow and liquidity, but the business is still deeply unprofitable and highly volatile. In Q1 2026, the company reported a large net loss of $26.4 million, yet it generated positive financing cash flow and ended the quarter with $7.36 million in cash and equivalents. The balance sheet also shows a much larger asset base than a year ago, but that growth comes with heavy intangible and “other asset” balances, as well as significant leverage and equity complexity.

  • Q1 2026 operating cash flow improved meaningfully from the prior quarter, with net cash from operating activities of ($4.9 million) versus ($998 thousand) in Q4 2025.
  • The company raised substantial capital in Q1 2026, including $10.0 million of common equity and $3.9 million of debt issuance, helping drive a $3.7 million increase in cash for the quarter.
  • Cash and equivalents rose to $7.36 million at March 31, 2026, up from $761 thousand at the end of Q3 2025.
  • Total assets expanded to $315.5 million in Q1 2026, reflecting a much larger operating footprint than in earlier periods.
  • The company reported $1.79 million of interest income in Q1 2026, suggesting meaningful investment income on securities holdings.
  • Quarterly revenue in Q1 2026 was $2.85 million, but this was not enough to offset expenses and nonoperating losses.
  • The quarter included a large nonoperating loss of ($21.2 million), which was the main driver of the bottom-line deficit.
  • Q1 2026 net loss widened to ($26.4 million), compared with ($11.0 million) in Q4 2025 and ($16.4 million) in Q3 2025.
  • The company posted a large ($4.6 million) operating cash outflow in Q1 2026, showing the core business is still not self-funding.
  • Nukkleus carries significant balance sheet risk, including $98.4 million of total liabilities and $174.6 million of redeemable noncontrolling interest, which complicates the equity structure.

Longer-term trend: Nukkleus has moved from periods of positive quarterly earnings in 2025 to much weaker results in late 2025 and early 2026. The business appears dependent on capital raises, securities-related income, and nonoperating items rather than stable operating profitability. While the recent cash build is a positive, investors should view the stock as highly speculative until operating losses narrow and the balance sheet becomes simpler and more durable.

07/21/26 05:53 PM ETAI Generated. May Contain Errors.

Nukkleus Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nukkleus' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Nukkleus' net income appears to be on an upward trend, with a most recent value of $78.63 million in 2025, falling from -$20.66 thousand in 2019. The previous period was -$8.52 million in 2024. Find out what analysts predict for Nukkleus in the coming months.

Over the last 6 years, Nukkleus' total revenue changed from $0.00 in 2019 to -$20.64 million in 2025, a change of -2,064,000,000.0%.

Nukkleus' total liabilities were at $45.19 million at the end of 2025, a 73.8% decrease from 2024, and a 21,867.7% increase since 2019.

In the past 6 years, Nukkleus' cash and equivalents has ranged from $19.32 thousand in 2023 to $6.90 million in 2024, and is currently $3.90 million as of their latest financial filing in 2025.

Over the last 6 years, Nukkleus' book value per share changed from 0.01 in 2019 to -2.37 in 2025, a change of -30,824.7%.


Related Companies

Financial statements for NASDAQ:DFNS last updated on 7/20/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel